Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2021 02:00 ET | Source: Steba biotech

Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer

Pivotal Phase 3 trial recruiting 100 patients, and examining complete response of tumors as the primary endpoint. Consists of induction and maintenance phases, with follow up 12 months post...
March 08, 2021 03:00 ET | Source: Steba biotech

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract Urothelial Cancer

Designation confers advantages including marketing exclusivity and tax credits Padeliporfin ImPACT pivotal Phase 3 trial in UTUC to start end Q1 2021 LUXEMBOURG, March 08, 2021 (GLOBE NEWSWIRE) --...